Jeffrey Wade
Henrietta Lacks, born Loretta Pleasant, was an African-American woman whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line. In 1951, doctors at Johns Hopkins Hospital took cervical cells from her tumour without her knowledge or consent, and these cells became the first human cells to continuously grow and reproduce in lab dishes. While HeLa cells have enabled countless scientific and medical innovations, including the development of the polio vaccine and genetic mapping, Henrietta's family has never received any compensation. They have faced challenges in obtaining health insurance and have only recently begun to receive settlements from biotechnology companies that profited from the cells. The story of Henrietta Lacks highlights ethical concerns in medical research and the importance of informed consent, particularly within the context of medical racism.
| Characteristics | Values |
|---|---|
| Did Henrietta Lacks have insurance? | No |
| Did Henrietta Lacks' family have insurance? | No |
| Did Henrietta Lacks receive compensation? | No |
| Did Henrietta Lacks' family receive compensation? | No |
| Did Henrietta Lacks give consent for her cells to be used? | No |
| Did Henrietta Lacks' family give consent for her cells to be used? | No |
| Did Henrietta Lacks receive free medical care? | No |
| Did Henrietta Lacks' family receive free medical care? | No |
| Did Henrietta Lacks' family file a lawsuit? | Yes |
| Did Henrietta Lacks' family receive a settlement? | Yes |
Explore related products
What You'll Learn
Henrietta Lacks' family lacked health insurance
Henrietta Lacks was an African-American woman whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line. In 1951, doctors at Johns Hopkins Hospital took cervical cells from Lacks without her knowledge or consent. These cells were cultured by George Otto Gey, who created the HeLa cell line, which is still used for medical research.
Lacks passed away on October 4, 1951, but her cells were just starting their immortal life. HeLa cells became a groundbreaking force in science, doubling every 24 hours and enabling scientists to perform experiments that were previously impossible. They have been used to develop the polio vaccine, study the effects of radiation and toxins on human cells, advance cancer and AIDS research, and facilitate gene mapping, cloning, and in vitro fertilization.
Despite the incalculable impact of HeLa cells, Henrietta Lacks' family has faced financial struggles, including a lack of health insurance. For decades, they lived in poverty, unable to afford health insurance, while corporations profited from Henrietta's cellular legacy. The family's difficulties in accessing healthcare were documented in Rebecca Skloot's bestselling book, "The Immortal Life of Henrietta Lacks."
The issue of health insurance for the Lacks family has sparked debates about compensation and ethical considerations. Some people argue that the family deserves health insurance and financial compensation for Henrietta's involuntary contribution to medical advancements. They suggest that Johns Hopkins Hospital or the companies profiting from HeLa cells should provide free medical care for her surviving children and grandchildren.
However, others raise concerns about the complexity of identifying and compensating all individuals involved in such cases. The Lacks family's struggle has highlighted the importance of informed consent and sparked conversations about race, medical exploitation, and tissue ownership. It has also contributed to new laws and regulations, such as the Henrietta Lacks Enhancing Cancer Research Act of 2019, which aims to address barriers to participation in federally funded cancer clinical trials for underrepresented populations.
Unclaimed Life Insurance: Who Benefits and How?
You may want to see also
Explore related products
Lacks' cells were used without consent
Henrietta Lacks, a young mother of five, walked into Johns Hopkins Hospital in 1951. She was diagnosed with an aggressive form of cervical cancer. During her treatment, doctors removed a sample of her cancer cells without her knowledge or consent and sent them to Dr George Gey, who was trying to find a cell line to use in cancer research.
At the time, collecting a patient's cells without their consent was legal. Lacks' cells defied the laws of biology—they didn't die after a few divisions but doubled every 24 hours. Named "HeLa" after the first two letters of her name, these cells became the first immortalised human cell line, enabling scientists to cultivate and reproduce studies using identical cells.
The HeLa cell line has since been used in countless medical breakthroughs, including the development of the polio and COVID-19 vaccines, genetic mapping, in vitro fertilisation, and research on cancer, AIDS, and viruses. However, the Lacks family has never received compensation for the use of Henrietta's cells, and they have struggled with poverty and a lack of health insurance.
In 2021, the Lacks family filed a lawsuit against Thermo Fisher, accusing the company of improperly profiting from HeLa cells. The lawsuit stated that more than 100 corporations had profited from HeLa cells while the Lacks family had not received any financial benefit. While Thermo Fisher argued that the case should be dismissed due to the statute of limitations, attorneys for the family countered that the company continued to benefit from the cells.
The story of Henrietta Lacks has brought to light important bioethical issues, including informed consent, medical records privacy, and communication with tissue donors and research participants. It has also become a symbol for a conversation about race, medical exploitation, and the ownership of bodily tissues.
Understanding the Legal Age for Life Insurance Policies
You may want to see also
Explore related products
Lacks' cells were the first immortalised human cell line
Henrietta Lacks, a young African-American mother of five, was diagnosed with an aggressive form of cervical cancer in 1951. She walked into Johns Hopkins Hospital in Baltimore, Maryland, with symptoms of irregular vaginal bleeding. Two samples were taken from her cervix without her permission or knowledge. One sample was of healthy tissue, while the other was cancerous. These samples were given to Dr. George Otto Gey, a physician and cancer researcher at Johns Hopkins.
Lacks's cancerous cells, known as HeLa cells, became a groundbreaking force in science. They were the first immortalized human cell line, meaning they could reproduce indefinitely under specific conditions. Unlike previous cell samples, which survived for only a few days, Lacks's cells doubled every 24 hours. This made them invaluable to medical research, as scientists could cultivate her cells indefinitely and reproduce studies using identical cells.
HeLa cells have been essential in numerous scientific landmarks, including the development of the polio vaccine, cloning, gene mapping, and in vitro fertilization. They have also been used to study the effects of radiation and toxins on human cells and to advance research on cancer, AIDS, and viruses. The cells were freely donated to any scientist who requested them, and they continue to be a source of invaluable medical data today.
The story of Henrietta Lacks highlights the ethical issues surrounding medical research and consent. Lacks and her family did not give permission for the cells to be harvested, and they never received compensation for their use. The cells were later commercialized, and companies have patented ways of using them, sparking debates about race, medical exploitation, and the ownership of human tissues.
Adjustable Life Insurance: Guaranteed Protection, Adjustable Coverage
You may want to see also
Explore related products
Lacks' cells were used to develop the polio vaccine
Henrietta Lacks was an African-American woman whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line. HeLa cells are one of the most important cell lines in medical research and were the first human cells to continuously grow and reproduce in lab dishes.
In 1938, President Franklin Delano Roosevelt, a polio victim himself, founded the National Foundation for Infantile Paralysis (NFIP) to raise funding for the treatment and cure of polio. The NFIP's mandate was to increase research and education on polio, specifically on the identification of its etiology and mode of transmission, and the development of treatment vaccines.
The Rhesus monkey cell was the initial cell of choice to measure the quantity of antibodies developed in response to the poliovirus infection. However, due to the inability to supply the large quantities of monkey cells needed for vaccine testing, an alternative source of host cells was required. The highly proliferative nature of the HeLa cell and its innate ability to be easily infected by the poliovirus made it an ideal alternative source.
By 1954, Jonas Salk was using HeLa cells in his research to develop the polio vaccine. To test his new vaccine, the cells were mass-produced in the first-ever cell production factory. The roller-tube technique was used to culture the cells, which were then injected into cancer patients, prison inmates, and healthy individuals to observe whether cancer could be transmitted. The Salk vaccine, or IPV, is based on three wild, virulent reference strains of poliovirus (Mahoney, MEF-1, and Saukett), grown in a type of monkey kidney tissue culture (Vero cell line), which are then inactivated with formalin. Oral polio vaccines (OPV) were later developed, which provided longer-lasting immunity than the Salk vaccine and were easier to administer as they eliminated the need for sterile syringes.
Life Insurance: A Necessary Safety Net?
You may want to see also
Explore related products
Lacks' family settled a lawsuit against a biotechnology company
Henrietta Lacks, a 31-year-old African-American mother of five, was diagnosed with an aggressive form of cervical cancer in 1951. She was admitted to Johns Hopkins Hospital in Baltimore, a racially segregated ward, where doctors removed cells from her cervical tumour without her consent. These cells, known as HeLa cells, were the first human cells to continuously grow and reproduce in laboratory settings. They became a cornerstone of modern medicine, enabling numerous scientific and medical innovations, including the development of the polio vaccine, genetic mapping, and even COVID-19 vaccines.
However, the story of Henrietta Lacks also highlights ethical concerns and issues of racial inequity in medical research. More than 70 years after her cells were taken without permission, her family filed a lawsuit in 2021 against a biotechnology company, Thermo Fisher Scientific, accusing them of improperly profiting from her cells. The lawsuit claimed that the company had made billions from tissue taken without Lacks' consent and that they had tried to secure intellectual property rights on products developed using the HeLa cells without compensating the family.
Thermo Fisher Scientific tried to dismiss the case, arguing that it was filed after the statute of limitations had expired. However, the family's attorneys countered that the statute of limitations should not apply because the company continued to benefit financially from the cells. In August 2023, it was announced that the Lacks family and Thermo Fisher Scientific had reached a settlement outside of court. The terms of the settlement are confidential and no financial payments or other details were disclosed.
The settlement has been hailed as precedent-setting, and the family's lawyers have indicated that they may pursue similar lawsuits against other companies that have profited from the HeLa cells or products based on them. The case has also sparked discussions about informed consent, medical exploitation, and the ownership of tissues, with some calling for compensation or health insurance for the Lacks family, who have lived in poverty while corporations profited from Henrietta Lacks' cellular legacy.
The story of Henrietta Lacks and the subsequent settlement have brought attention to the ethical dimensions of scientific progress and the need for better standards in healthcare and research to prevent medical exploitation, especially in communities of colour.
Life Insurance for Parents: Where to Get Covered
You may want to see also
Frequently asked questions
No, Henrietta Lacks did not have insurance.
No, Henrietta Lacks's family did not have insurance either.
No, Henrietta Lacks did not receive any compensation for her cells. However, in 2023, her family settled a lawsuit against a biotechnology company that profited from her cells.
No, Henrietta Lacks did not give consent for her cells to be used. At the time, it was not illegal to do so without a patient's permission.
